The battle against counterfeit medicines packaging

14 January 2020
pills_bottle_drugs_syringe_big

Underground criminals producing counterfeit goods have become alarmingly good at replicating manufacturers’ branding and are infiltrating the market. That’s a significant problem for both manufacturers and consumers, and the scale of the issue is rising.

The trade in counterfeit and pirated goods now accounts for 3% of all international business, worth $509 billion. Moreover, alarmingly, the most recent EU Customs report revealed that of all border seizures of counterfeit goods in 2018, 34% had the potential to harm consumers.

Along with food and alcohol, there are many other industries vulnerable to imitation. According to the European Alliance for Access to Safe Medicines, around 62% of medicines bought online are illegal. This figure is consistently growing at an alarming rate, which means brands need to think fast to tackle the issue.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical